SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jul 30, 17:00
3524.65
89.20 (+2.60%)
VOLUME 6,288
AVERAGE VOLUME
5-Day 1,507
10-Day 1,511
30-Day 1,872
VOLUME SHOCKER
5-Day 1,507
10-Day 1,511
30-Day 1,872
Prev. Close
3435.45
Open Price
3449.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 3440.60 3565.60
52 Wk Low/High 2400.00 3565.60
LIVE
NSE
Jul 30, 17:00
3531.75
86.70 (+2.52%)
VOLUME 58,311
AVERAGE VOLUME
5-Day 9,344
10-Day 10,636
30-Day 11,147
VOLUME SHOCKER
5-Day 9,344
10-Day 10,636
30-Day 11,147
Prev. Close
3445.05
Open Price
3450.00
Bid PRICE (QTY.)
3531.75 (544)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 3440.00 3574.00
52 Wk Low/High 2450.00 3574.00
Action in GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline
Sentimeter

86%14%
BUYSELL

86% of moneycontrol users recommend buying GlaxoSmithKline. What's your call on GlaxoSmithKline today?
Read 7 investor views

Consolidated
MARKET CAP (Rs Cr)
29,854.85
P/E
79.58
BOOK VALUE (Rs)
218.61
DIV (%)
625.00%
Market Lot
1
INDUSTRY P/E
34.28
EPS (TTM)
44.29
P/C
74.55
PRICE/BOOK
16.12
DIV YIELD.(%)
1.77%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
35.98 new
DELIVERY AVERAGES
3-Day 43.44%
5-Day 45.01%
8-Day 50.55%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track GlaxoSmithKline on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 31-Jul-2015 (Quarterly Results)
AGM
on 31-Jul-15 (Rs.62.5000 per share(625%)Dividend)
Book Closure
From 25-Jul-15 to 31-Jul-15 for Rs.62.5000 per share(625%)Dividend
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

30 July 2015

buy

INDO COUNT Jul Fut

Entry Price (Rs)

802.00

Exit Price (Rs)

824.50

Gain (Rs)

23.00

buy

TechMahindra Jul Fut

Entry Price (Rs)

523.50

Exit Price (Rs)

529.00

Gain (Rs)

5.00

buy

HCLTech Jul Fut

Entry Price (Rs)

963.00

Exit Price (Rs)

968.00

Gain (Rs)

5.00

buy

HDFC Jul Fut

Entry Price (Rs)

1,337.50

Exit Price (Rs)

1,347.00

Gain (Rs)

9.00

buy

Britannia Jul Fut

Entry Price (Rs)

2,997.00

Exit Price (Rs)

3,026.00

Gain (Rs)

29.00

buy

LeWaterina Jul Fut

Entry Price (Rs)

763.00

Exit Price (Rs)

798.00

Gain (Rs)

35.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 2493.80 3449.00  
High Price 2500.45 3565.60  
Low Price 2484.00 3440.60  
Last Price 2492.45 3524.65 41.41
Volume 1,360 6,288 362.35
Simple Moving Averages
Days BSE NSE
30 3357.93 3362.11
50 3298.98 3303.74
150 3249.82 3254.91
200 3157.73 3161.97

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for GlaxoSmithKline

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Mar'15 Dec'14 Jun'14
Mar'14
Net Sales 613.47 646.15 654.96 599.85
Other Income 40.48 37.77 39.84 44.88
PBDIT 125.77 114.67 114.21 107.60
Net Profit 102.85 45.30 98.29 96.54

Annual Report

Download in PDF format 2011 |2010
Balance Sheet
Mar'15
(In Rs Cr)
Total Share Capital 84.70
Net Worth 1,851.67
Total Debt 2.63
Net Block 123.06
Investments 47.67
Total Assets 1,854.30
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 814.30 -1.89 1200.70 766.65 195,960.98
Lupin 1626.40 -0.75 2112.00 1192.10 73,176.61
Dr Reddys Labs 3907.55 5.23 3960.00 2780.00 66,646.36
Cipla 710.10 4.79 752.45 437.75 57,028.47
Aurobindo Pharm 723.50 -0.92 1540.55 687.70 42,249.84
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Jun' 15Dec' 14Sep' 14Jun' 14
Promoter75.0075.0075.0075.00
FII2.142.062.052.64
DII9.369.559.528.90
Others13.5013.3913.4313.46
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Dr. Annie Besant Road ,
City
Mumbai
State
Maharashtra
Pin Code
400030
Tel. No.
022-24959595
Fax No.
022-24959494
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Plot No.17-24, Vittalrao Nagar, Madhapur
City
Hyderabad - 500081
State
Telangana
Tel. No.
040-23420815, 23420816, 23420817, 23420818
Fax No.
040-23420814
MANAGEMENT
Name
Designation
D S Parekh
Chairman
V Thyagarajan
Vice Chairman
H B Joshipura
Managing Director
R R Bajaaj
Director
A Bansal
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Zensar Technologies Recommended on Mar 24th 2015

Recommended price 623.00  |  Peak from reco 973.60 45.18%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About GlaxoSmithKline

GlaxoSmithKline is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 29,854.85 crore.

The company management includes D S Parekh - Chairman, V Thyagarajan - Vice Chairman, H B Joshipura - Managing Director, R R Bajaaj - Director, A Bansal - Director, P V Bhide - Director, N Kaviratne CBE - Director, R Krishnaswamy - Director, P V Nayak - Director, A N Roy - Director, R C Sequeira - Director, D Sundaram - Director, Regis Simard - Non Executive Director, Andrew Aristidou - Executive Director & CFO.

It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.

Its Registered office is at Dr. Annie Besant Road , Mumbai,Maharashtra - 400030.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of GlaxoSmithKline